Ocular Therapeutix Investor Relations Material
Latest events
Q2 2025
Ocular Therapeutix
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ocular Therapeutix Inc
Access all reports
Ocular Therapeutix Inc is a biopharmaceutical company focused on the development and commercialization of therapies for diseases and conditions of the eye. The company specializes in proprietary hydrogel-based drug delivery platforms designed for ophthalmology treatments. Ocular Therapeutix serves the healthcare sector by addressing needs in areas such as post-surgical inflammation, dry eye disease, and retinal diseases. The company is headquartered in Bedford, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Ocular Therapeutix Inc
Corporate Presentation
Ocular Therapeutix Inc
Corporate Presentation
Ocular Therapeutix Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
OCUL
Country
🇺🇸 United States